Discriminating between latent and active tuberculosis: The role of interleukin-2 as biomarker

Journal of Infection

Volumn 70, Issue 4, 2015, Pages 429-431

  Mamishi, Setareh ^a,b   Pourakbari, Babak ^a   Marjani, Majid ^c   Bahador, Abbas ^a   Mahmoudi, Shima ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; CHEMOKINE; CYTOKINE;

BACTERIUM CULTURE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IRAN; LATENT TUBERCULOSIS; LETTER; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS TEST KIT; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; BLOOD; FEMALE; MALE; TUBERCULOSIS;

CHEMOKINES; CYTOKINES; FEMALE; HUMANS; LATENT TUBERCULOSIS; MALE; TUBERCULOSIS;

EID: 84926123717     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.12.011     Document Type: Letter

References (10)

1. Mihret A., Bekele Y., Bobosha K., Kidd M., Aseffa A., Howe R., et al. Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infection. J Infect Apr 2013, 66(4):357-365.
2. Prezzemolo T., Guggino G., La Manna M.P., Di Liberto D., Dieli F., Caccamo N. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis. Front Immunol 2014, 5.
3. Mamishi S., Pourakbari B., Teymuri M., Rubbo P.A., Tuaillon E., Keshtkar A.A., et al. Diagnostic accuracy of IL-2 for the diagnosis of latent tuberculosis: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis Dec 2014, 33(12):2111-2119.
4. Dooms H., Kahn E., Knoechel B., Abbas A.K. IL-2 induces a competitive survival advantage in T lymphocytes. J Immunol 2004, 172(10):5973-5979.
5. Wang S., Diao N., Lu C., Wu J., Gao Y., Chen J., et al. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population. PloS One 2012, 7(12):e51338.
6. Biselli R., Mariotti S., Sargentini V., Sauzullo I., Lastilla M., Mengoni F., et al. Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls. Clin Microbiol Infect Aug 2010, 16(8):1282-1284.
7. Wang X., Cao Z., Jiang J., Niu H., Dong M., Tong A. Association of mycobacterial antigen-specific CD4(+) memory T cell subsets with outcome of pulmonary tuberculosis. J Infect Feb 2010, 60(2):133-139.
8. Mamishi S., Pourakbari B., Marjani M., Mahmoudi S. Diagnosis of latent tuberculosis infection among immunodeficient individuals: review of concordance between interferon-gamma release assays and the tuberculin skin test. Br J Biomed Sci 2014, 71(3):115-124.
9. Petruccioli E., Petrone L., Vanini V., Sampaolesi A., Gualano G., Girardi E., et al. IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis. J Infect 2013, 66(6):475-486.
10. Gourgouillon N., de Lauzanne A., Cottart C.-H., Curis E., Debord C., Guérin-ElKhourouj V., et al. TNF-[alpha]/IL-2 ratio discriminates latent from active tuberculosis in immunocompetent children: a pilot study. Pediatr Res 2012, 72(4):370-374.